Dashboard
1
With a growth in Net Profit of 87.94%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 533.37 MM
- ROCE(HY) Highest at 13.2%
- RAW MATERIAL COST(Y) Fallen by -205.71% (YoY)
2
With ROE of 11.31%, it has a very attractive valuation with a 1.04 Price to Book Value
Stock DNA
Other Agricultural Products
CNY 1,854 Million (Small Cap)
9.00
NA
0.00%
0.55
11.31%
1.04
Revenue and Profits:
Net Sales:
674 Million
(Quarterly Results - Mar 2026)
Net Profit:
176 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
35.56%
0%
35.56%
6 Months
27.97%
0%
27.97%
1 Year
66.87%
0%
66.87%
2 Years
-28.61%
0%
-28.61%
3 Years
-14.08%
0%
-14.08%
4 Years
-36.53%
0%
-36.53%
5 Years
-51.97%
0%
-51.97%
Shanghai Xuerong Biotechnology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.53%
EBIT Growth (5y)
6.51%
EBIT to Interest (avg)
-2.40
Debt to EBITDA (avg)
44.06
Net Debt to Equity (avg)
1.44
Sales to Capital Employed (avg)
0.64
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.01%
ROE (avg)
1.48%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.04
EV to EBIT
11.88
EV to EBITDA
5.78
EV to Capital Employed
1.03
EV to Sales
1.29
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
8.63%
ROE (Latest)
11.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
673.80
662.70
1.67%
Operating Profit (PBDIT) excl Other Income
188.50
189.00
-0.26%
Interest
9.40
16.00
-41.25%
Exceptional Items
0.00
0.00
Consolidate Net Profit
175.70
94.60
85.73%
Operating Profit Margin (Excl OI)
279.80%
161.00%
11.88%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 1.67% vs 25.25% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 85.73% vs 130.17% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,987.20
2,142.20
-7.24%
Operating Profit (PBDIT) excl Other Income
412.00
203.70
102.26%
Interest
61.30
98.90
-38.02%
Exceptional Items
0.30
-362.00
100.08%
Consolidate Net Profit
38.40
-616.40
106.23%
Operating Profit Margin (Excl OI)
36.00%
-81.90%
11.79%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -7.24% vs -15.81% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 106.23% vs -220.54% in Dec 2024
About Shanghai Xuerong Biotechnology Co., Ltd. 
Shanghai Xuerong Biotechnology Co., Ltd.
Other Agricultural Products
No Details Available.
Company Coordinates 
No Company Details Available






